Loading insider details...
Latest Form 4 (Aug 27, 2026): Sale of 14,036 ACRV shares, $31.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 27, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Sale | 14,036 | $31.0K |
| Aug 20, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Sale | 1,229 | $2.5K |
| May 26, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 13,729 | $24.6K |
| May 20, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 180,095 | n/a |
| May 18, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 1,253 | $2.4K |
| Mar 3, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 417,210 | n/a |
| Feb 24, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 14,265 | $21.8K |
| Feb 18, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 1,302 | $2.1K |
| Jan 16, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Purchase | 49,000 | $82.1K |
| Nov 25, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 19,904 | $45.8K |